Question 1

Is Bupivacaine-Hydrochloride-Monohydrate currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Bupivacaine-Hydrochloride-Monohydrate has 17 active shortage notices across 5 countries (United States, New Zealand, Australia, Canada, Ireland). Status is refreshed daily from official regulatory sources.

Question 2

Why is Bupivacaine-Hydrochloride-Monohydrate in shortage?

Accepted Answer

Regulators attribute the current Bupivacaine-Hydrochloride-Monohydrate shortages to product discontinuation, supply-chain disruption, manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Bupivacaine-Hydrochloride-Monohydrate shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 22 May 2026 to 22 May 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Bupivacaine-Hydrochloride-Monohydrate shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
United States	critical	6	4 Aug 2016	—	FDA, FDA-FE
New Zealand

Bupivacaine-Hydrochloride-Monohydrate shortage status

Where Bupivacaine-Hydrochloride-Monohydrate is in shortage

Why Bupivacaine-Hydrochloride-Monohydrate is in shortage

Recent shortage history

Frequently asked questions

Related medicines

Get alerted when Bupivacaine-Hydrochloride-Monohydrate status changes